File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Short-term therapeutic outcome of intra-articular high molecular weight hyaluronic acid injection for nonreducing disc displacement of the temporomandibular joint

TitleShort-term therapeutic outcome of intra-articular high molecular weight hyaluronic acid injection for nonreducing disc displacement of the temporomandibular joint
Authors
Issue Date2006
PublisherMosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/tripleo
Citation
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology And Endodontology, 2006, v. 102 n. 4, p. 453-461 How to Cite?
AbstractIn a patient with temporomandibular disorder who does not respond to conservative treatment, treatment with intra-articular injection of high molecular weight sodium hyaluronate can be suggested. In our study, 27 patients with nonreduced disc displacement were diagnosed clinically and confirmed by magnetic resonance imaging. The age range was from 21 to 63 years old, with a mean of 39.3 years. Two cycles of injection of high molecular weight sodium hyaluronate was performed on alternative weeks. Pain intensity was measured by the visual analog scale. Maximal mouth opening, clicking joint noise, and lateral movement were measured before and after injection for more than 6 months. Reduction of pain intensity and improvement in the maximum mouth opening parameter was statistically significant. In conclusion, this intra-articular injection using high molecular weight sodium hyaluronate looks very positive for patients affected by nonreduced disc displacement and is encouraged to be used as a primary treatment of temporomandibular joint dysfunction. © 2006 Mosby, Inc. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/154425
ISSN
2011 Impact Factor: 1.457
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorYeung, RWKen_US
dc.contributor.authorChow, RLKen_US
dc.contributor.authorSamman, Nen_US
dc.contributor.authorChiu, Ken_US
dc.date.accessioned2012-08-08T08:25:15Z-
dc.date.available2012-08-08T08:25:15Z-
dc.date.issued2006en_US
dc.identifier.citationOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology And Endodontology, 2006, v. 102 n. 4, p. 453-461en_US
dc.identifier.issn1079-2104en_US
dc.identifier.urihttp://hdl.handle.net/10722/154425-
dc.description.abstractIn a patient with temporomandibular disorder who does not respond to conservative treatment, treatment with intra-articular injection of high molecular weight sodium hyaluronate can be suggested. In our study, 27 patients with nonreduced disc displacement were diagnosed clinically and confirmed by magnetic resonance imaging. The age range was from 21 to 63 years old, with a mean of 39.3 years. Two cycles of injection of high molecular weight sodium hyaluronate was performed on alternative weeks. Pain intensity was measured by the visual analog scale. Maximal mouth opening, clicking joint noise, and lateral movement were measured before and after injection for more than 6 months. Reduction of pain intensity and improvement in the maximum mouth opening parameter was statistically significant. In conclusion, this intra-articular injection using high molecular weight sodium hyaluronate looks very positive for patients affected by nonreduced disc displacement and is encouraged to be used as a primary treatment of temporomandibular joint dysfunction. © 2006 Mosby, Inc. All rights reserved.en_US
dc.languageengen_US
dc.publisherMosby, Inc. The Journal's web site is located at http://www.elsevier.com/locate/tripleoen_US
dc.relation.ispartofOral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontologyen_US
dc.subject.meshAdulten_US
dc.subject.meshDislocations - Drug Therapyen_US
dc.subject.meshFacial Pain - Drug Therapyen_US
dc.subject.meshFemaleen_US
dc.subject.meshFollow-Up Studiesen_US
dc.subject.meshHumansen_US
dc.subject.meshHyaluronic Acid - Administration & Dosageen_US
dc.subject.meshInjections, Intra-Articularen_US
dc.subject.meshMagnetic Resonance Imagingen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshMolecular Weighten_US
dc.subject.meshRange Of Motion, Articularen_US
dc.subject.meshTemporomandibular Joint Disorders - Drug Therapyen_US
dc.subject.meshTreatment Outcomeen_US
dc.titleShort-term therapeutic outcome of intra-articular high molecular weight hyaluronic acid injection for nonreducing disc displacement of the temporomandibular jointen_US
dc.typeArticleen_US
dc.identifier.emailSamman, N:nsamman@hkucc.hku.hken_US
dc.identifier.authoritySamman, N=rp00021en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/j.tripleo.2005.09.018en_US
dc.identifier.pmid16997111-
dc.identifier.scopuseid_2-s2.0-33748751963en_US
dc.identifier.hkuros127666-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-33748751963&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume102en_US
dc.identifier.issue4en_US
dc.identifier.spage453en_US
dc.identifier.epage461en_US
dc.identifier.isiWOS:000241115200007-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridYeung, RWK=7102833345en_US
dc.identifier.scopusauthoridChow, RLK=14621379900en_US
dc.identifier.scopusauthoridSamman, N=7006413627en_US
dc.identifier.scopusauthoridChiu, K=36950846800en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats